02.13.13
• US Patent No. 8,337,869 B2; Two people from California have been awarded a patent for a topical composition having anti-inflammatory properties.
It consists of at least one complexed trace mineral consisting of copper organically bound to pyrrolidone carboxylate forming a copper-amino acid chelate; dipotassium glycyrrhizinate; at least one herbal extract; methyl salicylate; a component selected from the group consisting of methylsulfonylmethane, at least one non-steroidal anti-inflammatory alone or in combination, lysine-aspartate, at least one steroidal anti-inflammatory alone or in combination, and at least one non-steroidal anti-inflammatory and at least one non-steroidal anti-inflammatory and a pharmaceutically acceptable carrier composition.
The patent was awarded to Robert L. Gross and Nancy L. Leventoff, both of Foster City, CA.
It consists of at least one complexed trace mineral consisting of copper organically bound to pyrrolidone carboxylate forming a copper-amino acid chelate; dipotassium glycyrrhizinate; at least one herbal extract; methyl salicylate; a component selected from the group consisting of methylsulfonylmethane, at least one non-steroidal anti-inflammatory alone or in combination, lysine-aspartate, at least one steroidal anti-inflammatory alone or in combination, and at least one non-steroidal anti-inflammatory and at least one non-steroidal anti-inflammatory and a pharmaceutically acceptable carrier composition.
The patent was awarded to Robert L. Gross and Nancy L. Leventoff, both of Foster City, CA.